Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
The DOI matches its Crossref record.
Abstract
Micro- and macrovascular complications are major causes of disability and death in patients with diabetes mellitus. Functional impairment of endothelial activity precedes the development of morphological alterations during the progression of diabetes. This endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO), mainly due to accelerated NO degradation by reactive oxygen species (ROS). Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via several distinct mechanisms, increased oxidative stress seems to be the first alteration triggering several others. Mechanisms proposed to explain glucose- and lipid-induced vascular alterations in diabetes include accelerated formation of advanced glycation end-products (AGEs), protein kinase C activation, inflammatory signaling and oxidative stress. Insulin resistance with impaired PI 3-kinase effects decreases insulin mediated production of NO and reduces vasodilation, capillary recruitment and antioxidant properties of endothelium. Compensatory hyperinsulinemia enhances activation of intact MAP-kinase pathways and contributes to pro-atherogenic events by increasing secretion of endothelin-1 (ET-1), stimulating expression of adhesion molecules such as VCAM-1 and E-selectin, and inducing production of ROS. Conventional therapies to reduce hyperglycemia, dyslipidemia and insulin resistance may effectively improve endothelial function and delay the onset of vascular complications. Novel therapeutic approaches designed to inhibit AGEs formation, reduce PKC activation, decrease inflammatory signals and restore the ox/redox balance of endothelium may be predicted to ameliorate vascular function in diabetic state. This review summarizes the current knowledge on the most important mechanisms involved in endothelial dysfunction during diabetes. In addition, novel therapeutic strategies that may result from recently identified targets are also described.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [29]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 280
Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
Tentolouris, A., Eleftheriadou, I., Tzeravini, E., Tsilingiris, D., Paschou, S. Α., Siasos, G., & Tentolouris, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190119154152 · Cited by 34
Xuan, M., Okazaki, M., Iwata, N., Asano, S., Kamiuchi, S., Matsuzaki, H., Sakamoto, T., Miyano, Y., IIZUKA, H., & Hibino, Y. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/865986 · Cited by 32
Zaghloul, A., Albukhari, T. A., AL-Pakistani, H. A., Shalaby, M., Halawani, S. H., Bajuaifer, N., & Teama, S. H. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.007 · Cited by 30
PETROFSKY, J. S., Berk, L., & Alnakhli, H. H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/657103 · Cited by 35
Manea, S., Todirita, A., & Manea, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084170 · Cited by 29
Formoso, G., Tomo, P. D., Andreozzi, F., Succurro, E., Silvestre, S. D., Prudente, S., Perticone, F., Trischitta, V., Sesti, G., Pandolfi, A., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq255 · Cited by 29
Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats
Crespo, M. J. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1168 · Cited by 31
Sohrab, G., Nasrollahzadeh, J., Tohidi, M., Zand, H., & Nikpayam, O. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0146 · Cited by 27
Zhang, Y., Pan, Y., Li, J., Zhang, Z., He, Y., Yang, H., & Zhou, P. (2022) · Molecules · doi:10.3390/molecules27051457 · Cited by 27
Potenza, M. A., Nacci, C., Salvia, M. A. D., Sgarra, L., Collino, M., & Montagnani, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.009 · Cited by 27
Self-citationMatsumoto, T., Watanabe, S., Kawamura, R., Taguchi, K., & Kobayashi, T. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.11.016 · Cited by 26
Bashar, T., & Akhter, N. (2015) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v40i2.25226 · Cited by 27
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes
Xiao, Q., Wang, D., Li, D., Huang, J. H., Ma, F., Zhang, H., Sheng, Y., Zhang, C., & Ha, X. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108565 · Cited by 29
Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions
Zhang, J., Zhang, X., Li, H., Cui, X., Guan, X., Tang, K., Jin, C., & Cheng, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112444639 · Cited by 25
The Metabolic Syndrome: An Overview and Proposed Mechanisms
Thomaz, F. S., John, O. D., Sinha, P., Shafie, S. R., & Worrall, S. (2024) · Obesities · doi:10.3390/obesities4030020 · Cited by 35
The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
Kourtidou, C., & Τζιόμαλος, Κ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24066007 · Cited by 29
Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency
Yassin, A. A., Akhras, F., El‐Sakka, A. I., & Saad, F. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.01021.x · Cited by 25
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
Dai, D., & Dai, Y. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6556 · Cited by 30
Tousoulis, D., Koniari, K., Antoniades, C. A., Miliou, A., Noutsou, M., Nikolopoulou, A., Παπαγεωργίου, Ν., Marinou, K., Stefanadi, E., & Stefanadis, C. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.09.007 · Cited by 27
Recent advances in drug discovery for diabetic kidney disease
Danta, C. C., Boa, A. N., Bhandari, S., Sathyapalan, T., & Xu, S. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1832077 · Cited by 24
Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury
Huang, J., Lin, W., Sun, Y., Wang, Q., He, S., Han, Z., Lu, L., Kang, X., Chen, Y., Guo, H., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.944195 · Cited by 25
Oak, J., Youn, J.-Y., & Cai, H. “. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-65 · Cited by 23
Stem cells in the diabetic infarcted heart
Glass, C. E., Singal, P. K., & Singla, D. K. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9172-8 · Cited by 22
Induced Pluripotent Stem Cell–Derived Endothelial Cells in Insulin Resistance and Metabolic Syndrome
Carcamo‐Orive, I., Huang, N. F., Quertermous, T., & Knowles, J. W. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309291 · Cited by 22
Zhu, T., Wang, H., Wang, L., Zhong, X., Huang, W., Deng, X., Guo, H., Xiong, J., Xu, Y., & Fan, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7378 · Cited by 28
Arrick, D. M., & Mayhan, W. G. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00042.x · Cited by 21
Osman, A., Benameur, T., Korashy, H. M., Zeidan, A., & Agouni, A. (2020) · Biomedicines · doi:10.3390/biomedicines8100409 · Cited by 23
Yan, L., Hao, H., Elton, T. S., Liu, Z., & Ou, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0870-x · Cited by 21
Lu, Y., Li, H., Jian, W., Zhuang, J., Wang, K., Peng, W., & Xu, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1125 · Cited by 21
Nacci, C., Leo, V., Benedictis, L. D., Potenza, M. A., Sgarra, L., Salvia, M. A. D., Quon, M. J., & Montagnani, M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.08.007 · Cited by 23
Self-citationProtective effect of resveratrol on methylglyoxal-induced endothelial dysfunction in aged rats
Taşatargil, A., Tanriover, G., Barutcigil, A., & Turkmen, E. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0986-x · Cited by 25
Rajendran, P., Alzahrani, A. M., Veeraraghavan, V. P., & Ahmed, E. A. (2021) · Toxins · doi:10.3390/toxins13110745 · Cited by 20
Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes
David, S. R. N., Lai, P. P. N., Chellian, J., Chakravarthi, S., & Rajabalaya, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-39442-6 · Cited by 24
Haines, R. J., Corbin, K. D., Pendleton, L. C., Meininger, C. J., & Eichler, D. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.074 · Cited by 21
Sonobe, T., Tsuchimochi, H., Schwenke, D. O., Pearson, J. T., & Shirai, M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0217-0 · Cited by 23
Wang, Z., Chen, G., Yu, G., & Liu, C. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.4 · Cited by 21
Zhang, J., & Yan, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01241 · Cited by 21
Bhailis, A. M. D., Azmi, S., & Kalra, P. A. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211020664 · Cited by 21
Nuthikattu, S., Milenković, D., Norman, J., & Villablanca, A. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166970 · Cited by 22
Verma, A., & Sharma, S. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.02.019 · Cited by 19
Losso, J. N. (2022) · Molecules · doi:10.3390/molecules27051623 · Cited by 24
Zhang, Z., Li, Y., & Li, Y. (2016) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2016.1154020 · Cited by 19
Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta.
Abbasnezhad, A., Niazmand, S., Mahmoudabady, M., Soukhtanloo, M., Rezaee, S. A., & Mousavi, S. M. (2016) · PubMed Central · Cited by 20
Glabridin protects osteoblastic MC3T3-E1 cells against antimycin A induced cytotoxicity
Choi, E. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.05.007 · Cited by 19
Marie, P. K., & Jain, S. K. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2009-3 · Cited by 20
Automated Quantification Reveals Hyperglycemia Inhibits Endothelial Angiogenic Function
Prisco, A. R., Bukowy, J. D., Hoffmann, B. R., Karcher, J. R., Exner, E. C., & Greene, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094599 · Cited by 19
The role of Raf-1 kinase in diabetic retinopathy
Mohammad, G., & Kowluru, R. A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553604 · Cited by 17
Uslu, G. A., Gelen, V., Uslu, H., & Özen, H. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000317785 · Cited by 18
The critical role of dysregulated autophagy in the progression of diabetic kidney disease
Zhang, Z., Sun, Y., Xue, J., Jin, D., Li, X., Zhao, D., Lian, F., Qi, W., & Tong, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977410 · Cited by 15
Alaei-Shahmiri, F., Zhao, Y., & Sherriff, J. L. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0153-2 · Cited by 16
Guo, Y., Zhang, Q., Chen, H., Jiang, Y., & Gong, P. (2019) · Peptides · doi:10.1016/j.peptides.2019.170121 · Cited by 14
Ogiso, K., Shayo, S. C., Kawade, S., Hashiguchi, H., Deguchi, T., & Nishio, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263080 · Cited by 17
Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling
Smani, T., Gallardo, I., Ávila-Médina, J., Jiménez-Navarro, M. F., Ordóñez, A., & Hmadcha, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170523140925 · Cited by 13
Miner, M. M., Barnes, A., & Janning, S. W. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01766.x · Cited by 13
Luo, J., Li, X., Zhou, Y., Zhao, Q., Chen, B., Liu, F., Chen, X., Zheng, H., Ma, Y., Gao, X., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.01.005 · Cited by 15
van der Velden, A. I. M., IJpelaar, D. H. T., Shaw, P. K. C., Pijl, H., Vink, H., van der Vlag, J., Rabelink, T. J., & van den Berg, B. M. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00275-5 · Cited by 16
Lu, L., Zhang, R., Song, M., Zhou, S.-W., & Qian, G. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9775-5 · Cited by 12
Prasad, M., Lennon, R. J., Barsness, G. W., Prasad, A., Gulati, R., Lerman, L. O., & Lerman, A. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.09.171 · Cited by 12
Jabbar, T. L., & Kasim, A. A. (2020) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol29iss2pp263-270 · Cited by 11
The Effects of Taurine and Thiotaurine on Oxidative Stress in the Aorta and Heart of Diabetic Rats
Mathew, E., Barletta, M. A., & Lau‐Cam, C. A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6130-2_28 · Cited by 11
Suzuki, K., Watanabe, K., Suzuki, T., Ouchi, M., Futami‐Suda, S., Igari, Y., Nakano, H., & Oba, K. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.23053 · Cited by 14
Insulin rapidly stimulates l-arginine transport in human aortic endothelial cells via Akt
Kohlhaas, C. F., Morrow, V. A., Jhakra, N., Patil, V. R., Connell, J., Petrie, J. R., & Salt, I. P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.048 · Cited by 10
Abdelsalam, S. S., Pasha, M., Gamal, H. E., Hasan, M. H., Elrayess, M. A., Zeidan, A., Korashy, H. M., & Agouni, A. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12304 · Cited by 11
Wang, H., Yao, Y., Liu, J., Cao, Y., Si, C., Zheng, R., Zeng, C., Huaimin, G., & Li, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.080 · Cited by 10
Choi, S., Lee, J., Lee, J. H., Kim, S., Han, S., Kim, I., & Noh, Y. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2416 · Cited by 11
Baek, Y., Park, S., Kim, S.-H., Lee, M., Shin, S., Kim, D., Kwan, J., Park, K. S., & Woo, S. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.5.1235 · Cited by 10
Pharmacological therapies, lifestyle choices and nitric oxide deficiency: A perfect storm
Bryan, N. S. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.009 · Cited by 11
Jafarnezhad, F., Nazarzadeh, A., Bazavar, H., Keramat, S., Ryszkiel, I., & Stanek, A. (2025) · Nutrients · doi:10.3390/nu17162656 · Cited by 16
Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Valensi, P. E. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s3408 · Cited by 9
Selectins and Associated Adhesion Proteins in Inflammatory disorders
Gupta, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1065-2_44 · Cited by 11
Izumi, M., Seki, T., Iwasaki, K., & Sakamoto, K. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.219.53 · Cited by 9
Protective effect of α-lipoic acid against antimycin A cytotoxicity in MC3T3-E1 osteoblastic cells
Lin, Z., Zhang, G., Liu, L., Chen, C., Cao, X., & Cai, J. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0735-z · Cited by 10
Liu, W., Luo, Z., Zhang, L., Wang, Y., Yang, J., You, D., Cao, X., & Yang, W. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02077-0 · Cited by 9
Influence of Race, Gender, Age, and Diabetes on the Skin Circulation
PETROFSKY, J. S., & Bains, G. S. (2009) · Springer eBooks · doi:10.1007/978-3-540-89656-2_61 · Cited by 9
Talwar, A., Kumar, A., Bade, G., Trivedi, A., & Jyotsna, V. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.176343 · Cited by 9
Wearne, N., Davidson, B. J., Blockman, M., Jones, J., Ross, I. L., & Dave, J. A. (2023) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s396949 · Cited by 10
Arnhold, J. (2025) · Biomolecules · doi:10.3390/biom15040547 · Cited by 8
Genetic Determinants of Microvascular Complications in Type 1 Diabetes
Heltianu, C., Guja, C., & Mane, S.-A. (2011) · InTech eBooks · doi:10.5772/22065 · Cited by 9
Yeghiazaryan, K., Schild, H. H., & Golubnitschaja, O. (2012) · Infectious Disorders - Drug Targets · doi:10.2174/187152612804142215 · Cited by 8
Sj, B., Son, Y., & Ho, P. (2014) · PubMed · Cited by 8
Moreno, M., & Pearson, T. A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.442 · Cited by 11
Microvascular blood flow improvement in hyperglycemic obese adult patients by hypocaloric diet
Mastantuono, T., Maro, M. D., Chiurazzi, M., Battiloro, L., Starita, N., Nasti, G., Lapi, D., Iuppariello, L., Cesarelli, M., D’Addio, G., et al. (2016) · PubMed Central · doi:10.14273/unisa-2681 · Cited by 8
Pharmacokinetic and pharmacodynamic studies on flaxseed lignans
Mukker, J. K. (2013) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 11
Flores, K., Almeida, C., Arriaza, K., Pena, E., & Alam, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011023 · Cited by 10
Endothelin-1 promotes cytoplasmic accumulation of RIP140 through a ETA–PLCβ–PKCε pathway
Ho, P., Tsui, Y.-C., Lin, Y.-W., Persaud, S. D., & Wei, L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.003 · Cited by 11
Joshi, M. S., Wattanapitayakul, S. K., Schanbacher, B. L., & Bauer, J. A. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111416679 · Cited by 7
Román, M., Ramírez, J. M., Morales, M., & Crespo, M. J. (2019) · Pharmacological Reports · doi:10.1007/s43440-019-00038-5 · Cited by 7
Shairibha, S. M. R., & Rajadurai, M. (2014) · Cited by 7
Ellahham (2010) · Clinical Epidemiology · doi:10.2147/clep.s15162 · Cited by 6
Ceylan‐Isik, A. F., Arı, N., Štefek, M., Sotníková, R., Ozansoy, G., Horáková, Ľ., & Karasu, Ç. (2011) · Current Aging Science · doi:10.2174/1874609811104020150 · Cited by 6
PETROFSKY, J. S. (2011) · Journal of Medical Engineering & Technology · doi:10.3109/03091902.2011.592237 · Cited by 6
Homocysteine Excess and Vascular Endothelium Dysfunction: Delineating the Pathobiological Mechanisms
Bhatia, P., Gupta, S., & Sharma, S. (2014) · International Journal of Pharmacology · doi:10.3923/ijp.2014.200.212 · Cited by 6
GDPs and AGEs: impact on cardiovascular toxicity in dialysis patients.
Himmele, R., Sawin, D., & Díaz-Buxó, J. A. (2011) · PubMed · Cited by 6
Oxidant-induced disruption of vascular K + channel function: implications for diabetic vasculopathy
Nwokocha, C. R., Palacios, J. C., Ojukwu, V. E., Nna, V. U., Owu, D. U., Nwokocha, M., McGrowder, D. A., & Orie, N. N. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2090578 · Cited by 5
Yeghiazaryan, K., Peeva, V., Shenoy, A. R., Schild, H. H., & Golubnitschaja, O. (2011) · Infectious Disorders - Drug Targets · doi:10.2174/187152611795589717 · Cited by 5
Mingorance, C., de Sotomayor, M. Á., Marhuenda, E., & Herrera, M. D. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f7141a · Cited by 5
Vasodilator effects of cromakalim and HA 1077 in diabetic rat aorta
Gürpınar, T., & Gök, Ş. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13558 · Cited by 5
Potential risks of endoplasmic reticulum stress on vasculopathy in diabetes
Mustapha, S., Mohammed, M., Yunusa, I. U., Rasool, A. H. G., & Mokhtar, S. S. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100274 · Cited by 5
The ERM Complex: A New Player Involved in Diabetes-induced Vascular Leakage
Simó‐Servat, O., Hernández, C., & Simó, R. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181016162327 · Cited by 5
Metformin Had Potential to Increase Endocan Levels in STZ-Induced Diabetic Mice
Zolali, E., Shayesteh, S., Rahbarghazi, R., Vaez, H., Heidari, H. R., & Garjani, A. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.2 · Cited by 5
Metadata
- Authors
- Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M.
- Affiliations
- University of Bari Aldo Moro (IT)
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 94-112
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2116006961
- Cited by
- 280
- References
- 0
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 9 · 2020: 17 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 25
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- endothelial dysfunction, diabetes mellitus, nitric oxide bioavailability, reactive oxygen species, oxidative stress, advanced glycation end products, protein kinase C, insulin resistance, hyperinsulinemia, dyslipidemia, endothelin-1, adhesion molecules, vascular inflammation, PI3-kinase, MAPK signaling, diabetic vascular complications, therapeutic target
- MeSH terms
- Animals, Hypolipidemic Agents, Diabetic Angiopathies, Endothelium, Vascular, Humans, Hypoglycemic Agents, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.